Zivo Bioscience, Inc.
News
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Biosciences Coccidiosis Treatment in Broiler Chickens
Business Wire ZIVO Bioscience, Inc. (NASDAQ: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal...\n more…
Hedge Fund and Insider Trading News: Stanley Druckenmiller, Paul Marshall, Leon Cooperman, Odey Asset Management, Citadel LLC, Glen Point Capital, ZIVO Bioscience, Inc. (ZIVO), Keurig Dr Pepp
Insider Monkey Hedge Fund Odey Asset Management Winds Down After Sexual Misconduct Claims (The Wall Street Journal) Hedge Fund Billionaire Leon Cooperman, in Rare Public Rebuke of a Republican Candidate, Says Trump...\n more…
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
Business Wire Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the Company), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal...\n more…
Zivo Bioscience to effect reverse stock split to regain compliance with Nasdaq rules
Seeking Alpha - Healthcare Zivo Bioscience to effect reverse stock split to regain compliance with Nasdaq rules...\n more…
ZIVO Bioscience Announces Reverse Stock Split
Business Wire Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures...\n more…
Zivo Bioscience plans for stock and warrants offering - filing
Seeking Alpha - Healthcare Zivo Bioscience plans for stock and warrants offering - filing...\n more…